CLINICAL STUDY ANCILLARY SERVICES AGREEMENT SMLOUVA O DODATEČNÝCH SLUŽBÁCH V RÁMCI KLINICKÉ STUDIEClinical Study Ancillary Services Agreement • December 20th, 2021
THIS CLINICAL STUDY ANCILLARYSERVICES AGREEMENT (the “Agreement”), effective as of its Effective Date as defined above, is entered between Syneos Health UK Limited, with principal offices located in the United Kingdom at Farnborough Business Park, 1 Pinehurst Road, Farnborough, Hampshire, GU14 7BF, United Kingdom, VAT: GB 806650142, including its affiliates, subsidiaries, and specifically its parent company Syneos Health, LLC (“CRO”) acting for and on behalf of Incyte Corporation located at 1801 Augustine Cut-Off, Wilmington, Delaware 19803, U.S.A. (“Sponsor”), and Na Homolce Hospital (Nemocnice Na Homolce), having an address at Roentgenova 37/2, 150 30 Praha 5, Czech Republic (hereinafter referred to as the “Service Provider”). Hereinafter also jointly as “parties”. TATO SMLOUVA O DODATEČNÝCH SLUŽBÁCH V RÁMCI KLINICKÉ STUDIE(dále jen „smlouva“) účinná od data účinnosti uvedeného výše se uzavírá mezi Syneos Health UK Limited, se sídlem ve Spojeném království na adrese Farnborough Busin
